Annals of Surgical Oncology

, Volume 24, Issue 4, pp 1093–1099 | Cite as

Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer

  • David Liska
  • Luca Stocchi
  • Georgios Karagkounis
  • Faisal Elagili
  • David W. Dietz
  • Matthew F. Kalady
  • Hermann Kessler
  • Feza H. Remzi
  • James Church
Colorectal Cancer



Locoregional recurrence (LR) in colon cancer is uncommon but often incurable, while the factors associated with it are unclear. The purpose of this study was to identify patterns and predictors of LR after curative resection for colon cancer.


All patients who underwent colon cancer resection with curative intent between 1994 and 2008 at a tertiary referral center were identified from a prospectively maintained institutional database. The association of LR with clinicopathologic and treatment characteristics was determined using univariable and multivariable analyses.


A total of 1397 patients were included with a median follow-up of 7.8 years; 635 (45%) were female, and the median age was 69 years. LR was detected in 61 (4.4%) patients. Median time to LR was 21 months. On multivariable analysis, the independent predictors of LR were disease stage [hazard ratio (HR) for Stage II 4.6, 95% confidence interval (CI) 1.05–19.9, HR for Stage III 10.8, 95% CI 2.6–45.8], bowel obstruction (HR 3.8, 95% CI 1.9–7.4), margin involvement (HR 4.1, 95% CI 1.9–8.6), lymphovascular invasion (HR 1.9, 95% CI 1.06–3.5), and local tumor invasion (fixation to another structure, perforation, or presence of associated fistula, HR 2.2, 95% CI 1.1–4.5). Adjuvant chemotherapy was not associated with reduced LR in patients with either Stage II or Stage III tumors.


Adherence to oncologic surgical principles in colon cancer resection results in low rates of LR, which is associated with tumor-dependent factors. Recognition of these factors can help to determine appropriate postoperative surveillance.


Colon Cancer Rectal Cancer Total Mesorectal Excision Locoregional Recurrence Complete Mesocolic Excision 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Read TE, Mutch MG, Chang BW, et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg. 2002;195(1):33–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Sjovall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14(2):432–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Elferink MA, Visser O, Wiggers T, et al. Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol. 2012;19(7):2203–11.CrossRefPubMedGoogle Scholar
  5. 5.
    Dorrance HR, Docherty GM, O’Dwyer PJ. Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery. Dis Colon Rectum. 2000;43(4):492–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Harris GJ, Church JM, Senagore AJ, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029–34.CrossRefPubMedGoogle Scholar
  7. 7.
    Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115–22.CrossRefPubMedGoogle Scholar
  8. 8.
    Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(8):894–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.CrossRefPubMedGoogle Scholar
  10. 10.
    Birgisson H, Talback M, Gunnarsson U, Pahlman L, Glimelius B. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol. 2005;31(8):845–53.CrossRefPubMedGoogle Scholar
  11. 11.
    Lemmens V, van Steenbergen L, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975–2007: rectal cancer survival levels with colon cancer survival. Acta Oncol. 2010;49(6):784–96.CrossRefPubMedGoogle Scholar
  12. 12.
    Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007. doi: 10.1002/14651858.CD002200.pub2.
  13. 13.
    Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70.CrossRefPubMedGoogle Scholar
  14. 14.
    Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967;166(3):420–7.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Bowne WB, Lee B, Wong WD, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum. 2005;48(5):897–909.CrossRefPubMedGoogle Scholar
  16. 16.
    Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992;174(1):27–32.PubMedGoogle Scholar
  17. 17.
    Network NCC. Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer, Version 3.2014. Vol 20142014.Google Scholar
  18. 18.
    Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis. 2009;11(4):354–64; discussion 364-5.CrossRefPubMedGoogle Scholar
  19. 19.
    Kessler H, Hohenberger W. Extended lymphadenectomy in colon cancer is crucial. World J Surg. 2013;37(8):1789–98.CrossRefPubMedGoogle Scholar
  20. 20.
    Kobayashi H, West NP, Takahashi K, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21 Suppl 3:S398–404.CrossRefPubMedGoogle Scholar
  21. 21.
    West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28(2):272–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Abbas MA, Chang GJ, Read TE, et al. Optimizing rectal cancer management: analysis of current evidence. Dis Colon Rectum. 2014;57(2):252–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Martling A, Holm T, Rutqvist LE, et al. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg. 2005;92(2):225–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Nedrebo BS, Soreide K, Eriksen MT, et al. Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer. Br J Surg. 2011;98(5):716–23.CrossRefPubMedGoogle Scholar
  25. 25.
    Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol. 2001;19(18):3895–902.CrossRefPubMedGoogle Scholar
  26. 26.
    Madoff RD. Defining quality in colon cancer surgery. J Clin Oncol. 2012;30(15):1738–40.CrossRefPubMedGoogle Scholar
  27. 27.
    Kessler H, Mansmann U, Hermanek Jr P, Riedl S, Hermanek P. Does the Surgeon Affect Outcome in Colon Carcinoma? Semin Colon Rectal Surg. 1998;9(4):233–40.Google Scholar
  28. 28.
    West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9(9):857–65.CrossRefPubMedGoogle Scholar
  29. 29.
    Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263–70.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2016

Authors and Affiliations

  • David Liska
    • 1
  • Luca Stocchi
    • 1
  • Georgios Karagkounis
    • 1
  • Faisal Elagili
    • 1
  • David W. Dietz
    • 1
  • Matthew F. Kalady
    • 1
  • Hermann Kessler
    • 1
  • Feza H. Remzi
    • 1
  • James Church
    • 1
  1. 1.Department of Colorectal Surgery, Cleveland ClinicDigestive Disease InstituteClevelandUSA

Personalised recommendations